Therapeutic Potential of Thymoquinone and Its Nanoformulations in Pulmonary Injury: A Comprehensive Review

Naif A Al-Gabri,1,2 Sultan AM Saghir,3 Sallah A Al-Hashedi,4 Ali H El-Far,5 Asmaa F Khafaga,6 Ayman A Swelum,7 Abdullah S Al-wajeeh,8 Shaker A Mousa,9 Mohamed E Abd El-Hack,10 Mohammed AE Naiel,11 Khaled A El-Tarabily12,13 1Department of Pathology, Faculty of Veterinary Medicine, Thamar University,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Al-Gabri NA, Saghir SAM, Al-Hashedi SA, El-Far AH, Khafaga AF, Swelum AA, Al-wajeeh AS, Mousa SA, Abd El-Hack ME, Naiel MAE, El-Tarabily KA
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	anticancer activity antimicrobial activity bioavailability drug delivery molecular potential lung disease nanoparticle thymoquinone Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/5a36e55084654df7a1b133b6f0771755
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:5a36e55084654df7a1b133b6f0771755
record_format	dspace
spelling	oai:doaj.org-article:5a36e55084654df7a1b133b6f07717552021-12-02T16:17:35ZTherapeutic Potential of Thymoquinone and Its Nanoformulations in Pulmonary Injury: A Comprehensive Review1178-2013https://doaj.org/article/5a36e55084654df7a1b133b6f07717552021-07-01T00:00:00Zhttps://www.dovepress.com/therapeutic-potential-of-thymoquinone-and-its-nanoformulations-in-pulm-peer-reviewed-fulltext-article-IJNhttps://doaj.org/toc/1178-2013Naif A Al-Gabri,1,2 Sultan AM Saghir,3 Sallah A Al-Hashedi,4 Ali H El-Far,5 Asmaa F Khafaga,6 Ayman A Swelum,7 Abdullah S Al-wajeeh,8 Shaker A Mousa,9 Mohamed E Abd El-Hack,10 Mohammed AE Naiel,11 Khaled A El-Tarabily12,13 1Department of Pathology, Faculty of Veterinary Medicine, Thamar University, Dhamar, Yemen; 2Laboratory of Regional Djibouti Livestock Quarantine, Abu Yasar international Est. 1999, Arta, Djibouti; 3Department of Medical Analysis, Princess Aisha Bint Al-Hussein College of Nursing and Medical Sciences, AlHussein Bin Talal University, Ma’an, 71111, Jordan; 4Central Labs, King Faisal University, Al-Ahsa, Saudi Arabia; 5Department of Biochemistry, Faculty of Veterinary Medicine, Damanhour University, Damanhour, 22511, Egypt; 6Department of Pathology, Faculty of Veterinary Medicine, Alexandria University, Edfina, 22758, Egypt; 7Department of Theriogenology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, 44511, Egypt; 8Anti-Doping Lab Qatar, Doha, Qatar; 9Department of Pharmaceutical Sciences, the Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, 12144, USA; 10Poultry Department, Faculty of Agriculture, Zagazig University, Zagazig, 44519, Egypt; 11Animal Production Department, Faculty of Agriculture, Zagazig University, Zagazig, 44519, Egypt; 12Department of Biology, College of Science, United Arab Emirates University, Al-Ain, 15551, United Arab Emirates; 13Biosecurity and One Health Research Centre, Harry Butler Institute, Murdoch University, Murdoch, Western Australia, 6150, AustraliaCorrespondence: Khaled A El-Tarabily Email ktarabily@uaeu.ac.aeAbstract: As a crucial organ, the lung is exposed to various harmful agents that may induce inflammation and oxidative stress, which may cause chronic or acute lung injury. Nigella sativa, also known as black seed, has been widely used to treat various diseases and is one of the most extensively researched medicinal plants. Thymoquinone (TQ) is the main component of black seed volatile oil and has been proven to have antioxidant, anti-inflammatory, and antineoplastic properties. The potential therapeutic properties of TQ against various pulmonary disorders have been studied in both in vitro and in vivo studies. Furthermore, the application of nanotechnology may increase drug solubility, cellular absorption, drug release (sustained or control), and drug delivery to lung tissue target sites. As a result, fabricating TQ as nanoparticles (NPs) is a potential therapeutic approach against a variety of lung diseases. In this current review, we summarize recent findings on the efficacy of TQ and its nanotypes in lung disorders caused by immunocompromised conditions such as cancer, diabetes, gastric ulcers, and other neurodegenerative diseases. It is concluded that TQ nanoparticles with anti-inflammatory, antioxidant, antiasthma, and antitumor activity may be safely applied to treat lung disorders. However, more research is required before TQ nanoparticles can be used as pharmaceutical preparations in human studies.Keywords: anticancer activity, antimicrobial activity, bioavailability, drug delivery, molecular potential, lung disease, nanoparticle, thymoquinoneAl-Gabri NASaghir SAMAl-Hashedi SAEl-Far AHKhafaga AFSwelum AAAl-wajeeh ASMousa SAAbd El-Hack MENaiel MAEEl-Tarabily KADove Medical Pressarticleanticancer activityantimicrobial activitybioavailabilitydrug deliverymolecular potentiallung diseasenanoparticlethymoquinoneMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 16, Pp 5117-5131 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	anticancer activity antimicrobial activity bioavailability drug delivery molecular potential lung disease nanoparticle thymoquinone Medicine (General) R5-920
spellingShingle	anticancer activity antimicrobial activity bioavailability drug delivery molecular potential lung disease nanoparticle thymoquinone Medicine (General) R5-920 Al-Gabri NA Saghir SAM Al-Hashedi SA El-Far AH Khafaga AF Swelum AA Al-wajeeh AS Mousa SA Abd El-Hack ME Naiel MAE El-Tarabily KA Therapeutic Potential of Thymoquinone and Its Nanoformulations in Pulmonary Injury: A Comprehensive Review
description	Naif A Al-Gabri,1,2 Sultan AM Saghir,3 Sallah A Al-Hashedi,4 Ali H El-Far,5 Asmaa F Khafaga,6 Ayman A Swelum,7 Abdullah S Al-wajeeh,8 Shaker A Mousa,9 Mohamed E Abd El-Hack,10 Mohammed AE Naiel,11 Khaled A El-Tarabily12,13 1Department of Pathology, Faculty of Veterinary Medicine, Thamar University, Dhamar, Yemen; 2Laboratory of Regional Djibouti Livestock Quarantine, Abu Yasar international Est. 1999, Arta, Djibouti; 3Department of Medical Analysis, Princess Aisha Bint Al-Hussein College of Nursing and Medical Sciences, AlHussein Bin Talal University, Ma’an, 71111, Jordan; 4Central Labs, King Faisal University, Al-Ahsa, Saudi Arabia; 5Department of Biochemistry, Faculty of Veterinary Medicine, Damanhour University, Damanhour, 22511, Egypt; 6Department of Pathology, Faculty of Veterinary Medicine, Alexandria University, Edfina, 22758, Egypt; 7Department of Theriogenology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, 44511, Egypt; 8Anti-Doping Lab Qatar, Doha, Qatar; 9Department of Pharmaceutical Sciences, the Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, 12144, USA; 10Poultry Department, Faculty of Agriculture, Zagazig University, Zagazig, 44519, Egypt; 11Animal Production Department, Faculty of Agriculture, Zagazig University, Zagazig, 44519, Egypt; 12Department of Biology, College of Science, United Arab Emirates University, Al-Ain, 15551, United Arab Emirates; 13Biosecurity and One Health Research Centre, Harry Butler Institute, Murdoch University, Murdoch, Western Australia, 6150, AustraliaCorrespondence: Khaled A El-Tarabily Email ktarabily@uaeu.ac.aeAbstract: As a crucial organ, the lung is exposed to various harmful agents that may induce inflammation and oxidative stress, which may cause chronic or acute lung injury. Nigella sativa, also known as black seed, has been widely used to treat various diseases and is one of the most extensively researched medicinal plants. Thymoquinone (TQ) is the main component of black seed volatile oil and has been proven to have antioxidant, anti-inflammatory, and antineoplastic properties. The potential therapeutic properties of TQ against various pulmonary disorders have been studied in both in vitro and in vivo studies. Furthermore, the application of nanotechnology may increase drug solubility, cellular absorption, drug release (sustained or control), and drug delivery to lung tissue target sites. As a result, fabricating TQ as nanoparticles (NPs) is a potential therapeutic approach against a variety of lung diseases. In this current review, we summarize recent findings on the efficacy of TQ and its nanotypes in lung disorders caused by immunocompromised conditions such as cancer, diabetes, gastric ulcers, and other neurodegenerative diseases. It is concluded that TQ nanoparticles with anti-inflammatory, antioxidant, antiasthma, and antitumor activity may be safely applied to treat lung disorders. However, more research is required before TQ nanoparticles can be used as pharmaceutical preparations in human studies.Keywords: anticancer activity, antimicrobial activity, bioavailability, drug delivery, molecular potential, lung disease, nanoparticle, thymoquinone
format	article
author	Al-Gabri NA Saghir SAM Al-Hashedi SA El-Far AH Khafaga AF Swelum AA Al-wajeeh AS Mousa SA Abd El-Hack ME Naiel MAE El-Tarabily KA
author_facet	Al-Gabri NA Saghir SAM Al-Hashedi SA El-Far AH Khafaga AF Swelum AA Al-wajeeh AS Mousa SA Abd El-Hack ME Naiel MAE El-Tarabily KA
author_sort	Al-Gabri NA
title	Therapeutic Potential of Thymoquinone and Its Nanoformulations in Pulmonary Injury: A Comprehensive Review
title_short	Therapeutic Potential of Thymoquinone and Its Nanoformulations in Pulmonary Injury: A Comprehensive Review
title_full	Therapeutic Potential of Thymoquinone and Its Nanoformulations in Pulmonary Injury: A Comprehensive Review
title_fullStr	Therapeutic Potential of Thymoquinone and Its Nanoformulations in Pulmonary Injury: A Comprehensive Review
title_full_unstemmed	Therapeutic Potential of Thymoquinone and Its Nanoformulations in Pulmonary Injury: A Comprehensive Review
title_sort	therapeutic potential of thymoquinone and its nanoformulations in pulmonary injury: a comprehensive review
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/5a36e55084654df7a1b133b6f0771755
work_keys_str_mv	AT algabrina therapeuticpotentialofthymoquinoneanditsnanoformulationsinpulmonaryinjuryacomprehensivereview AT saghirsam therapeuticpotentialofthymoquinoneanditsnanoformulationsinpulmonaryinjuryacomprehensivereview AT alhashedisa therapeuticpotentialofthymoquinoneanditsnanoformulationsinpulmonaryinjuryacomprehensivereview AT elfarah therapeuticpotentialofthymoquinoneanditsnanoformulationsinpulmonaryinjuryacomprehensivereview AT khafagaaf therapeuticpotentialofthymoquinoneanditsnanoformulationsinpulmonaryinjuryacomprehensivereview AT swelumaa therapeuticpotentialofthymoquinoneanditsnanoformulationsinpulmonaryinjuryacomprehensivereview AT alwajeehas therapeuticpotentialofthymoquinoneanditsnanoformulationsinpulmonaryinjuryacomprehensivereview AT mousasa therapeuticpotentialofthymoquinoneanditsnanoformulationsinpulmonaryinjuryacomprehensivereview AT abdelhackme therapeuticpotentialofthymoquinoneanditsnanoformulationsinpulmonaryinjuryacomprehensivereview AT naielmae therapeuticpotentialofthymoquinoneanditsnanoformulationsinpulmonaryinjuryacomprehensivereview AT eltarabilyka therapeuticpotentialofthymoquinoneanditsnanoformulationsinpulmonaryinjuryacomprehensivereview
_version_	1718384232727838720

Therapeutic Potential of Thymoquinone and Its Nanoformulations in Pulmonary Injury: A Comprehensive Review

Ejemplares similares